One might even say it was old wine inOne might even say it was old wine in new bottles.
One might even say it was old wine inOne might even say it was old wine in new bottles.
Right, but you quoted my post, and for criticism, and I originally only wanted to point out, that algorithms and the likes are by far not bound to BSP models and the likes.Sorry, perhaps I wasn't clear. The "algorithms" view I was referring to above is in fact the predictive coding model of functional movement disorders that is described in the paper at the top of this thread.
People are developing ‘functional neurological’ issues downstream of having taken GP prescribed antidepressants, benzodiazepines, etc. (on- or off-label, sometimes long-term) for various ‘indications’. As these prescribed drugs are designed to cross the blood-brain barrier and to act on the central and autonomic nervous systems this must surely be significant? We know from recently published work by Hengartner, Davies & Read 2020 (2) that a high percentage of people (46%) experience ‘severe’ withdrawals from antidepressants.
Thanks for posting, @Sly Saint. I read through the letter, and felt pretty angry at Stone et al. for giving patients the false impression that they believe FND is a neurological disorder ("corruption of the brain-generated predictions and interference from the limbic system and amygdala"). If you strip off the layers, its clear they think the key determinant of who gets FND and who doesn't is personality and psychopathology. These are the characteristics they believe to be the root cause of the "interference from the limbic system and the amygdala" that is at play. The proposed solutions are entirely behavioural (therapy and exercise).
In a funny twist, I don't think the effort will ever work out because no matter how they coat and distort what they mean, other physicians understand very well that this means psychosomatic and thus not medically relevant, so will pay little attention to it.Thanks for posting, @Sly Saint. I read through the letter, and felt pretty angry at Stone et al. for giving patients the false impression that they believe FND is a neurological disorder ("corruption of the brain-generated predictions and interference from the limbic system and amygdala"). If you strip off the layers, its clear they think the key determinant of who gets FND and who doesn't is personality and psychopathology. These are the characteristics they believe to be the root cause of the "interference from the limbic system and the amygdala" that is at play. The proposed solutions are entirely behavioural (therapy and exercise).
I remember a book that came out in the 70s called "how to lie with statistics", and it struck me that this is the modern equivalent "how to lie with neuroscience".
Stone et al have clearly succeeded, because this group sees hope that their illness will now be taken seriously. And maybe they are partly right, because this new language might prove more acceptable to friends and family (let's face it, its a way more acceptable story than having to tell people you have ME or CFS). But at the end of it is just therapy and retraining and the same old cycles of hope and then self-blame when it all fails. Plus, each iteration of this new model takes us further and further away from actually understanding what's at the bottom of these various movement disorders and how we might actually treat them successfully.
Thread continues for a few more posts on Twitter.
Put succinctly, FMD patients have a body-focused attentional bias, subsequently driving abnormal perceptions/movements.
No, apparently not. And even if the results were negative, this group's appraoch means that they would not see a need to revise the model. There have been a number of recent attempts to link FND with psychological characteristics or adverse life exepriences, and all have failed - - and this group have used that, not to challenge their conceptions, but to argue for using an even looser set of criteria to diagnose it.Would there not need to be a prospective study before one could assert that FMD patients have a body-focused attentional bias? Has there ever been such a study?
Rapid Response:
The curious challenge of breaking good news
Stone and colleagues (1) present useful guidance regarding assessment and management of patients with functional neurological disorder (FND). Unfortunately, clinicians caring for those with other ‘functional’ syndromes often face rather more fraught and complex challenges.
Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are examples of common presentations which have also attracted the ‘functional' label due to persisting uncertainty regarding aetiology and pathophysiology; optimal management is consequently challenging (2,3). FND is typically identified by overt physical signs; even when these are absent, as in dissociative seizures, it is often possible to give significant weight to features in the history (1). By contrast, the absence of physical signs and the lack of symptom specificity in CFS and FM can be a source of doubt, dispute, and stigma for all concerned (4, 5).
As Stone et al demonstrate, clinical findings enable the positive diagnosis of FND in tandem with judicious diagnostic testing to exclude relevant pathologies (1). By contrast, many other functional syndromes are identified in a negative sense, only after often extensive physical investigations have excluded demonstrable pathology. This conclusion is generally less satisfying and a frequent source of frustration for both patients and clinicians (4, 5). Doctors thus often find themselves in the difficult position of breaking unwelcome ‘good news’ to patients hungry for a mechanistic explanation of their symptoms. Recognising and skillfully managing patients’ emotional investment in having a physical diagnosis is crucial in avoiding the dual risks of over-investigation and overtreatment (6).
1) Stone J, Burton C, Carson A. Recognising and explaining functional neurological disorder. BMJ. 2020;371:m3745. doi: 10.1136/bmj.m3745.
2) Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics (Basel). 2019;9:80. doi: 10.3390/diagnostics9030080.
3) Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011;7:518-27. doi: 10.1038/nrrheum.2011.98.
4) Boulton T. Nothing and everything: Fibromyalgia as a diagnosis of exclusion and inclusion. Qual Health Res. 2019;29:809-819. doi: 10.1177/1049732318804509.
5) Houwen J, Lucassen PL, Stappers HW, Assendelft WJ, van Dulmen S, Olde Hartman TC. Improving GP communication in consultations on medically unexplained symptoms: a qualitative interview study with patients in primary care. Br J Gen Pract. 2017;67:e716-e723. doi: 10.3399/bjgp17X692537.
6) Williams N, Wilkinson C, Stott N, Menkes DB. Functional illness in primary care: dysfunction versus disease. BMC Family Practice. 2008;9:30.
Competing interests: No competing interests
13 November 2020
David B Menkes
academic psychiatrist
Sean L Davidson
University of Auckland
Waikato Hospital, Hamilton, New Zealand
@davidmenkes